申请人:——
公开号:US20040010017A1
公开(公告)日:2004-01-15
This application relates to a compound of formula I (or a prodrug thereof or a pharmaceutically acceptable salt of the compound or prodrug thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.
本申请涉及到公式I的化合物(或其前药或其药学上可接受的盐或前药),如本文所定义,以及其药物组合物,以及其作为因子Xa抑制剂的用途,以及其制备方法和中间体。